Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy

In this study we looked at the outcome for testicular cancer in more than 1000 patients treated at a single institution in the USA. We found that the treatment for metastatic disease differed between older (≥40 yr) and younger patients. Furthermore, outcomes for older patients (≥40 yr) were worse than for younger men.